Log In or Create Account
CROI
Conference on Bacteriophages
RWHAP Clinical Conference
Podcasts
Key Slides
Question of the Week
Donate
Contact
Advanced Search
CME Courses
HIV In-Person and Virtual Courses
Current On-Demand Courses
About Courses
CME Webinars
Upcoming Webinars
Current On-Demand Webinars
MATE Act CME
About Webinars
Dialogues
Upcoming IAS–USA Dialogues
On-Demand Dialogues
About Dialogues
Topics In Antiviral Medicine
Current Issues for CME
Previous Issues
TAM
Policies and Practices
Permission Request Form
HIV Drug Resistance
Muta Chart
Recent Webinars
Journal Articles
Fellow Resources
Fellow Resources
IAS-USA Guidelines
On-Demand Webcasts
Research Collaborations
Additional Resources
About
Scientific Leadership Board
IAS-USA Leadership Award Recipients
Core Faculty
Mission
Staff
CME
Funding Information
Careers
Website Policies
Governance
FAQs
Menu
Topics in Antiviral Medicine
™
December 2021/January 2022
Volume 29, Issue 5
Download here
, or select individual articles
Claim CME
Invited Reviews
Chronic Pain and Opioid Use in Older People With HIV
Vasudev C. Mandyam, MD, R. Douglas Bruce, MD, MA, MS
Neurocognition and the Aging Brain in People With HIV: Implications for Screening
Phillip Chan, MBChB, PhD, Victor Valcour, MD, PhD
Perspective
Addressing the Challenges of Vaccine Hesitancy Broadly and Related to COVID-19 Vaccines
Marie T. Brown, MD, Constance A. Benson, MD
Topics in Antiviral Medicine™
Current Issues
Previous Issues
TAM
Policies and Practices
TAM
Author and Contributor Guidelines
Topics in Antiviral Medicine
Editorial Board
CROI
Conference on Bacteriophages
RWHAP Clinical Conference
Podcasts
Key Slides
Question of the Week
Donate
Contact
CME Courses
HIV In-Person and Virtual Courses
Current On-Demand Courses
About Courses
CME Webinars
Upcoming Webinars
Current On-Demand Webinars
MATE Act CME
About Webinars
Dialogues
Upcoming IAS–USA Dialogues
On-Demand Dialogues
About Dialogues
Topics In Antiviral Medicine
Current Issues for CME
Previous Issues
TAM
Policies and Practices
Permission Request Form
HIV Drug Resistance
Muta Chart
Recent Webinars
Journal Articles
Fellow Resources
Fellow Resources
IAS-USA Guidelines
On-Demand Webcasts
Research Collaborations
Additional Resources
About
Scientific Leadership Board
IAS-USA Leadership Award Recipients
Core Faculty
Mission
Staff
CME
Funding Information
Careers
Website Policies
Governance
FAQs
Practice Question of the Week
October 7, 2024: Prevention and Treatment of Influenza in People With HIV
A 48-year-old patient with well-controlled HIV and diabetes mellitus has been feeling sick for 4 days with myalgia, headache, cough, and fever. He develops tachypnea and is admitted to the hospital for low oxygen saturation. Chest radiography show diffuse, hazy infiltrates. Which of the following is the best next step?
A. Test for SARS-CoV-2. He has had symptoms for 4 days, so it will be too late to treat for flu if he has it
B. Test for SARS-CoV-2 and influenza. Await results
C. Obtain a (1,3)-β-d-glucan (BDG) test and induced sputum. Start trimethoprim/sulfamethoxazole
D. Test for SARS-CoV-2 and influenza. Start oseltamivir while awaiting results
E. Start ceftriaxone and azithromycin without any viral testing
View On-Demand Webinar
View Archived Questions
Leave Feedback
Subscribe
CLOSE